Skip to main content

Opinion: Did the Oxford COVID-19 vaccine work in monkeys? Not really

By Forbes  
   May 17, 2020

The day after data appeared from the vaccine maker Sinovac showed complete protection of rhesus monkeys by their vaccine candidate (whole inactivated SARS-CoV-2 virus particles), scientists from the Jenner Institute in Oxford issued a press release announcing that their vaccine (an adenovirus vector based vaccine that carried the SARS-CoV-2 spike protein) worked to protect rhesus monkeys and that they were moving forward with large scale human safety trials.

Full story


Get the latest on healthcare leadership in your inbox.